Ovarian cancer can be classified into Type I (more indolent tumours lacking mutations in TP53) and Type II (aggressive cancers displaying TP53 mutations in >80% of cases), which account for most of the OC mortality) (Kurman and Shih, 2010). Here, TP53 is linked to ovarian carcinoma.